NG JenniferPartner
Jennifer has extensive experience representing leading corporates and investment banks on capital markets transactions, with a particular focus on Hong Kong initial public offerings (IPOs) and listing matters. She has advised on high-profile Hong Kong IPOs across a range of sectors, including technology, healthcare and consumer products. She also advises companies listed on the Hong Kong Stock Exchange on compliance matters, significant corporate transactions (including public takeovers) and corporate governance issues. Prior to joining Jia Yuan, Jennifer worked at several leading international law firms.
E-mail:jennifer.ng@jiayuanlaw.com.hk
Language:Chinese, English
Representative Deals
- Extreme Vision, Quantgroup, Jihong, Horizon Robotics*, Kingsoft Cloud*, Tencent Music*, KE Holdings*, Zhida Technology*, GenFleet Therapeutics*, PegBio*, Mirxes*, Baicha Baidao*, Lianlian DigiTech*, HighTide Therapeutics*, Keep*, Cutia Therapeutics*, Beisen*, Biocytogen Pharmaceuticals*, CANbridge Pharmaceuticals*, ANE*, Okura*, Fu Shou Yuan*, Macau Legend*, Future Land*, Sihuan Pharmaceutical*, Mingfa Group*, Little Sheep*, Pacific Textiles*, Sino Gold Mining*, Okura*, Shinelong Automotive*, Hevol Services*, ELL Environmental*, IBI Group*, GHW International*, Design Capital*, Grace Wine*, etc.
*select experience prior to joining Jia Yuan
Honor
- IFLR1000 – Capital Markets: Equity, M&A – Notable practitioner
- ALB – “Young Lawyer of the Year”, 2019
Education
- PCLL, University of Hong Kong
- LL.B., B.A., University of Hong Kong
Bar Admission